6th Biomarker Development Conference
Register 2, the 3rd goes free with the coupon code rcdvb!
Download the Biomarker Summit 2012 Brochure

Dear Colleague,

GTC is proud to present the 6th Biomarker Development Conference as part of the Biomarker Summit 2012.

Returning for its sixth installment, the Conference will once again be the gathering center for professionals in the biomarker development industry.

Biomarker Development remains one of the most important aspects in the pharmaceutical industry and will continue to push advancements well into the future. As the nearly $13 billion biomarker market continues to advance, its complexity grows as well. It is essential that the industry is in tune with the latest developments and breakthroughs, especially in the current economic and regulatory environment. Only those armed with the highest caliber intelligence will be able to compete and continue to contribute to this vital industry.

The 6th Biomarker Development Conference offers attendees insight into the latest developments from the leading players will offering a unique networking opportunity.

Beyond simply attending a conference, attendees will be part of the larger Biomarker Summit 2012 that also includes:

Biomarker and Diagnostics Conference
4th Oncology Biomarker Conference
Biomarker Partnering and Deal-Making Conference

Limitless networking opportunities will be provided for attendees across all four Summit tracks. We look forward to welcoming you to the Biomarker Summit 2012!

The Conference features the following sessions:

Plenary Session

Regulatory & Policy Update: Carolyn Compton, MD, Ph.D., President & CEO, Critical Path Institute

Keynote Speaker: Steven J. Skates, Ph.D., Associate Professor of Medicine, Massachusetts General Hospital Cancer Center

Keynote Speaker: Prof. Dr. med. Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer HealthCare

6th Biomarker Development Conference

Personalized Medicine for Non-Oncology uses (Dual Track)

Next Generation Sequencing and Discovery of New Diagnostics (Dual Track)

Biomarker Validation of Preclinical to Clinical Studies

Shortening Development Times with Biomarker Defined Patient Populations

Biomarkers in Clinical Trials

Analytics in Biomarker Development

New Technologies and Novel Approaches in Biomarker Development

Kind Regards,

2012 Conference Advisory Committee

Attend ALL 2012 GTCbio Conferences for only $3995 industry rate or $1990 acad/govt rate.
Click here to sign up!